Congress has singled out pharmacy benefit managers, holding 20 hearings while calling on drug companies only a handful of ...

President Donald Trump took aim at that pricing disparity with an executive order on May 12 that aims to lower drug prices for U.S. consumers and taxpayers, sharing on social media that they'd be cut ...

President Trump will sign an executive order Monday that he says will drop the prices of prescription drugs between 30-80% ...

Every policymaker in America, on both sides of the aisle, wants to lower prescription drug costs. There is a basic ...

After months of failed litigation from drugmakers, CMS released negotiated list prices for 10 of the country’s most expensive drugs. The Inflation Reduction Act, signed into law in August 2022 ...

One complicating factor is manufacturer rebates, which are discounts on prescription list prices provided by drug manufacturers to pharmacy benefit managers, which in turn may share some or all of ...

Pharmacy benefit managers ... rebating practices of the three companies have led to artificially inflated list prices for people. List prices are what a drugmaker initially sets for a product ...

If the suit is successful, it could further drive down costs for patients at the pharmacy counter ... are based on a percentage of a drug’s list price. Essentially, in the case of insulin ...

PBMs “systematically excluded them in favor of identical high list price, highly rebated versions,” the FTC alleges. The Federal Trade Commission sued the three dominant pharmacy-benefit ...